142 related articles for article (PubMed ID: 27077768)
1. Moderate-dose cyclophosphamide in the treatment of relapsed/refractory T-cell large granular lymphocytic leukemia-associated pure red cell aplasia.
Peng G; Yang W; Zhang L; Zhou K; Li Y; Li Y; Ye L; Li J; Fan H; Song L; Zhao X; Wu Z; Zhang F; Jing L
Hematology; 2016 Apr; 21(3):138-43. PubMed ID: 27077768
[TBL] [Abstract][Full Text] [Related]
2. Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study Group.
Fujishima N; Sawada K; Hirokawa M; Oshimi K; Sugimoto K; Matsuda A; Teramura M; Karasawa M; Arai A; Yonemura Y; Nakao S; Urabe A; Omine M; Ozawa K;
Haematologica; 2008 Oct; 93(10):1555-9. PubMed ID: 18641028
[TBL] [Abstract][Full Text] [Related]
3. [Efficacy of Oral Cyclophosphamide for Treatment of Refractory T-cell Large Granular Lymphocytic Leukemia Accompanied with Pure Erythrocyte Aplastic Anemia].
Zhao Y; Chen ZW; Ye HY; Gu J; Xu XL; Qi YL; Ling YW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Apr; 28(2):418-423. PubMed ID: 32319372
[TBL] [Abstract][Full Text] [Related]
4. [The clinical and laboratory characteristics of T cell large granular lymphocyte leukemia].
Zhao X; Zhou K; Wang HJ; Zhang L; Liu QG; Jing LP; Li HQ; Yang DL; Chu YL; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2009 Mar; 30(3):179-82. PubMed ID: 19642367
[TBL] [Abstract][Full Text] [Related]
5. [A case of pure red cell aplasia accompanied with granular lymphocytic leukemia the tumor cells of which suppressed colony formation of BFU-E, and which was successfully treated by cyclophosphamide and cyclosporin A].
Hirayama Y; Nagai T; Ohta H; Koyama R; Matsunaga T; Sakamaki S; Niitsu Y
Rinsho Ketsueki; 1997 Nov; 38(11):1206-11. PubMed ID: 9423339
[TBL] [Abstract][Full Text] [Related]
6. Clinical features and treatment outcomes in patients with T-cell large granular lymphocytic leukemia: A single-institution experience.
Zhu Y; Gao Q; Hu J; Liu X; Guan D; Zhang F
Leuk Res; 2020 Mar; 90():106299. PubMed ID: 32035354
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes in T-cell large granular lymphocytic leukaemia: prognostic factors and treatment response.
Braunstein Z; Mishra A; Staub A; Freud AG; Porcu P; Brammer JE
Br J Haematol; 2021 Feb; 192(3):484-493. PubMed ID: 32519348
[TBL] [Abstract][Full Text] [Related]
8. T-cell large granular lymphocyte leukemia: A report on the treatment of 29 patients and a review of the literature.
Osuji N; Matutes E; Tjonnfjord G; Grech H; Del Giudice I; Wotherspoon A; Swansbury JG; Catovsky D
Cancer; 2006 Aug; 107(3):570-8. PubMed ID: 16795070
[TBL] [Abstract][Full Text] [Related]
9. Treatment of T-cell large granular lymphocyte leukemia with cyclosporine A: experience in a Chinese single institution.
Zhao X; Zhou K; Jing L; Zhang L; Peng G; Li Y; Ye L; Li J; Fan H; Li Y; Zhang F
Leuk Res; 2013 May; 37(5):547-51. PubMed ID: 23395383
[TBL] [Abstract][Full Text] [Related]
10. Distinct effect of cyclophosphamide and cyclosporine on pure red cell aplasia associated with T-cell large granular lymphocyte leukemia.
Tabata R; Tabata C
Int Immunopharmacol; 2014 Dec; 23(2):391-4. PubMed ID: 25466263
[TBL] [Abstract][Full Text] [Related]
11. [The clinical characteristics of T cell large granular lymphocyte leukemia associated with pure red cell aplasia].
Zhou K; Wang HJ; Zhang L; Li HQ; Yang DL; Yan ZS; Jing LP; Wu YH; Chu YL; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2008 May; 29(5):312-5. PubMed ID: 18844068
[TBL] [Abstract][Full Text] [Related]
12. Mixed-phenotype large granular lymphocytic leukemia: a rare subtype in the large granular lymphocytic leukemia spectrum.
Neff JL; Rangan A; Jevremovic D; Nguyen PL; Chiu A; Go RS; Chen D; Morice WG; Shi M
Hum Pathol; 2018 Nov; 81():96-104. PubMed ID: 29949739
[TBL] [Abstract][Full Text] [Related]
13. Pure red cell aplasia associated with large granular lymphocytic leukemia: a rare association in Western countries.
García Vela JA; Pérez V; Monteserin MC; Oña F
Haematologica; 1998 Jul; 83(7):664-5. PubMed ID: 9718874
[TBL] [Abstract][Full Text] [Related]
14. Prolonged complete hematologic response in relapsed/refractory T-large granular lymphocyte leukemia after bendamustine treatment.
Rosamilio R; Giudice V; Ferrara I; Annunziata S; Pezzullo L; Villani G; Baldi C; Guariglia R; Rocco M; Selleri C
Transl Med UniSa; 2016 Nov; 15():80-83. PubMed ID: 27896231
[TBL] [Abstract][Full Text] [Related]
15. STAT3 mutation and its clinical and histopathologic correlation in T-cell large granular lymphocytic leukemia.
Shi M; He R; Feldman AL; Viswanatha DS; Jevremovic D; Chen D; Morice WG
Hum Pathol; 2018 Mar; 73():74-81. PubMed ID: 29288042
[TBL] [Abstract][Full Text] [Related]
16. [Pure red cell aplasia with thymoma/T-cell large granular lymphocyte leukemia: two cases report and literatures review].
Zhao X; Zhou K; Ye L; Peng GX; Jing LP; Li Y; Li Y; Fan HH; Song L; Jing LP; Zhang L; Zhang FK
Zhonghua Xue Ye Xue Za Zhi; 2013 Jun; 34(6):536-9. PubMed ID: 23827115
[TBL] [Abstract][Full Text] [Related]
17. Clinical characteristics and treatment outcomes of Asian patients with T-cell large granular lymphocytic Leukemia: a single-center analysis of 67 cases.
Park T; Byun JM; Shin DY; Koh Y; Hong J; Yoon SS; Chang YH; Kim I
Ann Hematol; 2024 Apr; 103(4):1235-1240. PubMed ID: 38062223
[TBL] [Abstract][Full Text] [Related]
18. [Clinical study on regimen cyclophosphamide, Ara-C and topotecan (CAT) in treatment of patients with refractory or relapsed acute myelogenous leukemia].
Qin TJ; Xu ZF; Wang JY; Zhou CL; Xiao ZJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1342-6. PubMed ID: 19840480
[TBL] [Abstract][Full Text] [Related]
19. Pure red cell aplasia: association with large granular lymphocyte leukemia and the prognostic value of cytogenetic abnormalities.
Lacy MQ; Kurtin PJ; Tefferi A
Blood; 1996 Apr; 87(7):3000-6. PubMed ID: 8639922
[TBL] [Abstract][Full Text] [Related]
20. Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease.
Zawit M; Bahaj W; Gurnari C; Maciejewski J
Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
